Research in the field of human immunology is restricted by the lack of a system that 2 reconstitutes the in-situ activation dynamics of quiescent human antigen-specific T-cells 3 interacting with dendritic cells. Here we report a tissue-like system that recapitulates the 4 dynamics of engineered primary human immune cell. Our approach facilitates real-time single 5 cell manipulations, tracking of interactions and functional responses complemented by 6 population-based measurements of cytokines, activation status and proliferation. 
and more rarely humanised mouse models. Each of these tools has its limitation. Cell lines 19 have diverged tremendously from primary cells, making their signalling machinery and 20 response thresholds no longer representative; bulk peripheral blood assays lack the spatial 21 organisation of tissues; and humanised mouse models have only a portion of their system 22 "humanised", rendering the remaining parts confounding factors. To address these limitations, 23
we introduce a holistic approach to allow researchers to manipulate and study human immune 24 cells in a tissue-like environment with minimal aberrations to their natural behaviours. We 25 report a toolkit that achieves two critical goals for engineering T-cells: (1) high efficiency TCR 26 expression and maintenance of T-cell motility, activation dynamics and viability using mRNA 27 electroporation and (2) a tissue-like 3D culture (Scheme). 28 29
Successful engineering of T-cells involves the expression of a functional and stable 30
TCR, as well as the preservation of important cellular characteristics. One such characteristic 31 is cell motility which is essential for efficient antigen search. Here, we have optimised the 32 procedures to engineer naïve human CD4 and CD8 T-cells using mRNA electroporation. The 33 common approach to render T-cells antigen specific relies on lentiviral transduction of the TCR 34 expression and assembly at the cell surface, this was achieved by introducing cysteine 11 modifications in the TCR chains ( Supplementary Fig. 1b and Table 1) 7 , as well as co-12 transfection with the human CD3z ( Supplementary Fig. 1c ), as the endogenous protein is most 13 likely sequestered by the endogenous TCR limiting the expression of the introduced TCR. The 14 functionality of naïve CD8 T-cells following TCR electroporation was confirmed by the 15 formation of a mature immunological synapse (IS, Fig.1b) , and the upregulation of the 16 activation marker CD69 ( Supplementary Fig. 2a ). The efficiency of TCR expression varied 17 among donors with a mean value of 81 ± 7% (mean±SD, n=13), with more than 90% cell 18 viability and 80-90% cell recovery. 19
The induction of expression of an exogenous TCR in CD4 T-cells is considerably 20 harder than in CD8 T-cells 4 . Using natural sequences or the introduction of cysteine 21 modifications used for 1G4 and 868 failed to induce expression of TCRs in naïve CD4 T-cells. 22
However, replacing the constant region of the human TCR with that of mouse TCR (Table 2 ) 23 8 allowed for successful chain pairing and we were able to achieve expression in 72 ± 8.9% 24 (mean±SD, n=15) of the cells detected using H57 mAb against the mouse Cb. We have 25 successful expressed three different HLA-DPB1*04 restricted TCRs in naïve CD4s: 6F9 26 (Fig.1c) and R12C9, both specific to the MAGE-A3 protein 9 and SG6 specific for NY-ESO 27 10 ( Supplementary Fig. 1d ). The expression of SG6 was consistently lower than 6F9 and 28 R12C9 in naïve CD4 T-cells. However, when the same TCRs were electroporated into 29 previously activated CD4 T-cells, high expression levels were achieved in 97.8 ± 1% 30 (mean±SD, n=15) of the cells ( Supplementary Fig.1e ). The functionality of the naïve CD4 T-31 cells upon TCR electroporation was confirmed by IS formation (Fig. 1d ) and T-cell activation 32 ( Supplementary Fig. 2b) . 33
Using the square-wave electroporator we were able to maintain the motile behaviour 1 and interaction dynamics of naïve CD8 T-cells expressing 1G4, at similar levels to those of 2 untouched cells, on 2D stimulatory 'spots' ( Supplementary Fig. 3 , Video 1 and 11 ). 3 Naïve T-cells get activated by interacting with professional antigen presenting cells 4 (APCs); the most potent are dendritic cells (DCs). The closest model for bona fide DCs is 5 monocyte-derived DCs (moDCs) with well-established protocols for their generation. The 6 caveat with those protocols is their extended duration (7-10 days)
12 , a time-frame which may 7 alter autologous T-cells' phenotype. We therefore optimised a 48 h protocol 13 to generate fully 8 matured moDCs. During the first 24 h monocyte differentiation into DC was induced, followed 9 by 24 h maturation to get activated DCs (acDC) (Fig. 1e) . The "express" moDCs are able to 10 upregulate MHC and other costimulatory molecules to a similar extent as the "classical" moDC 11
( Supplementary Fig. 4a ) and produce a common profile of soluble factors ( Supplementary Fig.  12 4b). We have also quantified peptide loading on these cells and achieved levels similar to those 13 previously reported with other APCs (Supplementary Fig. 4c ) 14 . 14 15 T-cells and DCs interactions have been extensively studied in mice using explants and 16 intravital imaging 15 , such studies are practically impossible in humans. Furthermore, accurate 17 control and manipulation of parameters such as antigen dose and cell ratios is limited. Having 18 successfully engineered naïve human T-cells we set out to establish a flexible 3D platform to 19 interrogate their dynamics and interactions with APC using a multitude of correlated functional 20
readouts. The desired platform should: (1) support the culture of T-cells and APCs for multiple 21 days, (2) support the motility of the cells, (3) allow live imaging, (4) enable downstream 22 analysis and (5) be easy to use. To achieve these goals we chose collagen I based 3D matrices 16 , 23 which we optimised to support the culture of human immune cells. Culturing cells in the 24 presence of human serum (HS) results in better basal motility than FBS (Fig. 2a,  25 Supplementary Fig. 5a and Video 2), which is significantly enhanced by the addition of 26 homeostatic chemokines such as CCL19 (Supplementary Video 3), CCL21 and CXCL12 27 (Supplementary Video 4). However, only CXCL12 is able to maintain high motility in cultures 28 with FBS. We have explored different sources of collagen I (bovine, human and non-tryptic 29 collagen) and other complex extracellular matrices, ECM ( Supplementary Fig. 5b ). All 30 collagens were equally good in supporting motility and interactions, while more advanced 31 ECM may have a marginal advantage for motility. Yet, the larger batch variation, higher 32 background activation and the complexity in extracting cells for downstream analysis weighed 33 against adopting them for our assays. In our view, the use of bovine collagen-I as the 3D 34 scaffold, with human serum in media, and CXCL12 to enhance motility provides an optimal 1 3D system. 2
We present here a proof of concept to the usefulness of our set-up by interrogating naïve 3 CD8 T-cells activation. We used live cell imaging to follow the interactions in real-time by 4 upregulation of CD69 (Fig. 2b and Supplementary Video 5) as well as calcium flux 5
( Supplementary Fig. 6 , 7a and Video 6). We observed major changes in interaction dynamics 6 as a function of peptide affinity 17 (Fig. 2c) . A high affinity peptide, NY-ESO-9V, 7
(Supplementary Video 7) induced T-cell arrest, whereas a lower affinity peptide, NY-ESO-9L, 8
(Supplementary Video 8), led to similar dynamics as a null peptide (Supplementary Video 9) 9 where no stable contacts are formed. Since our 3D culture offers a relatively simple way to 10 extract cells for flow cytometry and downstream analyses, we were able to correlate the 11 interaction dynamics with the activation state of the cells and observe marginal differences in 12 the response relative to the major differences in dynamics (Fig. 2d) . Using our system, we are 13 also able to monitor cytokine production ( Supplementary Fig.7 b) , proliferation 14 ( Supplementary Fig. 7c ) and intracellular activation markers ( Supplementary Fig. 7d ). In order 15 to study the interaction dynamics of T-cells at different time points we can pre-load the acDCs 16 prior or following gel polymerisation to mimic the delivery of antigen to lymph nodes 17 (Supplementary Fig. 7e and Videos 10-11, respectively). Finally, since we are able to engineer 18 both CD4 and CD8 T-cells with unique TCRs we can interrogate the dynamics of CD4 T-cells 19 help to CD8 T-cells 18 (Fig. 2e, Supplementary Video 12) where the activation of CD4 T-cells 20 (Fig.2f , left) coincides with enhanced maturation of the acDCs (Fig. 2f, middle) and enhanced 21 activation of the CD8 T-cells (Fig. 2f, right) . 22
23
In this report, we present, to the best of our knowledge, a unique and first of its kind 24 holistic approach to engineer quiescent antigen specific human T-cells and study them in a 25 context akin to physiological settings. Our tools are widely applicable to generate T-cells 26 expressing different receptors and other proteins with high efficiency and minimal adverse 27 effects associated with other engineering methods, which are essential for implementation of a 28 successful translational approach. We provide a proof of concept where our system is used to 29 probe the dynamics of T-cell/APC interactions as a function of peptide affinity and recapitulate 30 CD4 help to CD8 T-cells. Our experimental approach can be further extended towards 31 reconstitution of more complex biology such as tumour infiltrating lymphocytes and the role 32 of regulatory T-cells in cancer. We believe that the mechanical and biophysical features 33 introduced by our platform provide greater fidelity to in vivo conditions and will improve 34 predictive power of pre-clinical studies in all human cell-based systems. We propose that our 1 system should be integrated with other classical and computational approaches to enhance 2 translational research. 
34
The sequences for the 1G4 TCR were provided by Vincenzo Cerundolo, the 868 TCR was provided by Andrew
35
Sewell, and all the MHC-II restricted TCRs (SG6, R12C9 and 6F9) were shared by Steven Rosenberg.
36
All TCRs were synthesised using GeneArt services from ThermoFisher, by adding Kozak sequence and codon 37 optimisation for human expression. The 1G4 and 868 were to include a cysteine modification in the alpha and 38 beta chains (see Supplementary table for sequences) .
39
The MHC-II restricted TCRs were synthesised so that the human constant region was replaced with the mouse 40 constant regions (see Supplementary table for sequences).
The alpha and beta chains were cloned separately into a pGEM-GFP-64A plasmid (gift of James Riley) between 
18 19
Express monocyte-derived dendritic cell generation
21
Monocytes were enriched from the same leukopoiesis products as T-cells using RosetteSep kits (Stemcell 
31
Peptide loading on DC was quantified using an AlexaFluor 647 conjugated high affinity soluble TCR (c113 32 against NY-ESO) with a known dye ratio and Quantum MESF AlexaFluor 647 beads as calibration (647, Bangs
33
Laboratories).
34
Secretion of soluble factors was assessed using 0.5 ml of culture medium, and the corresponding controls of media
35
containing the differentiation and activation cytokines, following the manufacturer's protocol (Proteom Profiler
36
Human XL Cytokine Array kit, ARY022B, R&D Systems). of HLA-A*02 in moDCs from donors which were HLA-A*02 negative using the mRNA electroporation 7 approach.
9 10
Engineering antigen specific T-cells
12
To express TCR constructs within resting naïve and memory T-cells, we used mRNA electroporation. mRNA
13
preparations of the relevant TCRa, TCRb and CD3z chains from a linearised pGEM-64A vector or a T7
14
containing PCR product was done using mMESSAGE mMACHINE T7 ULTRA Transcription kit as per 15 manufacturer's protocol (ThermoFisher, AM1345). The mRNA was purified using MegaClear kit (ThermoFisher,
16
AM1908) and was aliquoted and kept at -80 o C 19 . To achieve high efficiency of expression, mRNA quality was 17 assessed using agarose gels and samples showing any sign of degradation were discarded. Any mRNA preparation
18
with yields bellow 40 µg mRNA per 1 µg of DNA was considered of low quality, finally all mRNA aliquots were 19 stored at concentrations > 1 µg/µl, which can be achieved by concentrating the mRNA product using ammonium 
30
The exogenous TCR can be detected up to 96 h post electroporation.
32 33
Supported lipid bilayers (SLB) 34 35 SLBs were prepared as previously described 20 . In brief, piranha and plasma cleaned coverslips were mounted on 
39
Avanti Polar Lipids,). NTA-lipids were used at a final concentration of 2 mM and CapBio lipids were used at a 40 dilution resulting in site density of 30 molecules/μm 2 . SLBs were allowed to form by incubating the coverslips 1 with the appropriate LUVs for 20 min at room temperature (RT) followed by a wash with HEPES buffered saline 2 (HBS) Supplemented with 1 mM CaCl2 and 2 mM MgCl2, and human serum albumin (HBS/HSA). The SLBs 3 were loaded with saturating amounts of AlexaFluor568 labelled streptavidin, 5 µg/ml, (S11226, ThermoFisher)
4
for 10 min at RT followed by pMHC at 30 molecules/μm 2 and ICAM-1 200 molecules/μm 2 for 20 min at RT.
6 7
Micro-contact printed chambers 8 9
Micro-patterned surfaces presenting pMHC molecules were prepared using micro-contact printing by modifying 
24
into the channel at 2 μg/ml for 10 min at RT, washed and followed by 9V/A2 pMHC at 1 μg/ml for 20 min at RT.
26 27
Collagen gel chamber assembly 28 29
DC were loaded with the mentioned peptide for 90 min at 37 o C. For imaging experiments T-cells were labelled 30 with a volumetric dye as described below (Imaging) or loaded with cell trace violet (C34557, ThermoFisher) for 31 proliferation assays or otherwise kept unlabelled.
32
Collagen mix was made by modifying the approach of Gunzer et al 16 using 5 µl 7.5% sodium bicarbonate, 10 µl 33 10x MEM, 75 µl 3 mg/ml Bovine Collagen I (PureCol) and a chemokine, 1 µg/ml of CCL21 (300-35-100,
34
Peprotech) or CCL19 (300-29B, Peprotech) or 0.3 µg/ml of SDF1-a/CXCL12 (300-28A, Peprotech). All the work
35
with collagen was done on ice to prevent polymerisation. Other matrices tested: VitroCol Human Collagen I
36
(5007-A, CellSystems), Matrigel (at final conc. of ~4 mg/ml, two batches tested with similar results), and GelTrex
37
(A1413301, ThermoFisher, at final concentration of ~8 mg/ml, two batches tested with similar results). All 3D
38
cultures were made with Bovine Collagen I, except for the comparison shown in Supplementary Fig. 5 , and mainly
39
with CXCL12 unless otherwise stated. 
10
Extended culture in the 3D system leads to ~50% reduction in cell speed due to chemokine desensitisation and 11 can be overcome by the addition of fresh chemokine after 18 h.
13
Flow cytometry
15
1G4 TCR expression was assessed using 9V-HLA-A2 tetramers, 868 TCR expression was assessed using SL9-
16
HLA-A2 streptamers (6-7004-001, iba) and 6F9, SG6 and R12C9 expression was assessed with anti-mouse
17
TCR b (H57) antibody. The MHC II restricted TCRs seem to have very low affinity towards their antigen 18 preventing detection using tetramers (attempts to measure affinity using SPR suggest a Kd bellow 500 µM). In 
22
To analyse samples from collagen gels, the gels were first digested into solution using collagenase VII (Sigma 
25
Brefeldin A or monensin were added after 20 h for 2 h along with a stimulation of Phorbol 12-myristate 13-acetate
26
(PMA, P8139, Sigma) at 1 µg/ml and ionomycin (I0634, Sigma) at 1 µM, the cells were then stained using the
27
FoxP3 intracellular staining kit (00-5523-00, eBioscience) and the desired antibodies. For experiments measuring
28
LAMP1 expression, an antibody against it was added at the start of the culture.
30 31
Imaging 32 33
Cells are labelled with either one of the volumetric dyes, CMFDA (250 nM, ThermoFisher), CMRA (500 nM,
34
ThermoFisher) or Deep Red (100 nM, ThermoFisher) for 20 min in complete media. For imaging CD69 activation 35 the collagen mixture described above was supplemented with a BV421nlabelled anti-CD69 at 1 µg/ml
36
(adjustments in volume are made to the media to maintain the same final collagen concentration). For calcium
37
imaging T-cells were loaded with 1 µM of Fluo4-AM (ThermoFisher) for 20 min at 37 o C. Cells were imaged 38 using either a Dragonfly Spinning Disk system, a Perkin Elmer Spinning disk or an Olympus FluoView FV1200
39
confocal microscope using a 30x Super Apochromat silicone oil immersion objective with 1.05 NA. All 40 microscopes included an environmental chamber to maintain temperature at 37 o C and CO2 at 5%. Time-lapse 1 images were acquired every 30 or 60s. z-scans were acquired every 3 µm.
2
SLB imaging was performed on an Olympus IX83 inverted microscope equipped with a TIRF module and
3
Photomertrics Evolve delta EMCCD camera using an Olympus UApON 150x TIRF N.A 1.45 objective.
5 6
Data analysis
8
Microscopy data from collagen gels was rendered and analysed using IMARIS software (Bitplane) using built-in 9 analysis tools. Synapse images were analysed using Fiji. Image analysis for micro-contact printing data was done 10 using TIAM 21 as described in 11 . In brief, cells were tracked using DIC images. IRM and fluorescence signal- 
13
where A is cell number and k is the off-rate constant representing the exit from the spots by dissolution of the IS. 
11
Video 6 12 Maximum projection of 3D time-lapse of 1G4-expressing naïve CD8 T-cells (magenta), loaded with calcium dye 
16
Video 7
17
Maximum projection of 3D time-lapse of 1G4-expressing naïve CD8 T-cells (magenta), interacting with acDCs
18
(green) not loaded with NY-ESO antigenic peptide.
20
Video 8
21
Maximum projection of 3D time-lapse of 1G4-expressing naïve CD8 T-cells (magenta), interacting with antigen 22 loaded acDC (100 nM NY-ESO-9V, green).
24
Video 9
25
Maximum projection of 3D time-lapse of 1G4-expressing naïve CD8 T-cells (magenta), interacting with antigen 26 loaded acDC (100 nM NY-ESO-9L, green).
28
Video 10
29
3D reconstruction of 1G4-expressing naïve CD8 T-cells (magenta), interacting with antigen loaded acDC (100
30
nM NY-ESO-6T, green).
32
Video 11
33
3D reconstruction of 1G4-expressing naïve CD8 T-cells (magenta), interacting initially unloaded acDCs
34
(green), where the peptide was later added after collagen polymerisation to a final concentration of 100 nM NY-
35
ESO-6T.
37
Video 12
38
3D reconstruction of 1G4-expressing naïve CD8 T-cells (magenta), 6F9-expressing naïve CD4 T-cells (cyan)
39
interacting with antigen loaded DCs (100 nM NY-ESO-6T and 10 µM MAGE-A3243-258).
